Kan danske registre anvendes ved utilsigtede haendelser ved type 2-diabetes?

Medicin og biovidenskab

• Registries 100%
• Type 2 Diabetes Mellitus 94%
• Delivery of Health Care 76%
• Pharmaceutical Preparations 52%
• National Health Programs 44%
• Angiotensin II Type 2 Receptor Blockers 36%
• Medicine 30%
• Diagnosis-Related Groups 24%
• Angiotensin-Converting Enzyme Inhibitors 20%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 20%
• Hypoglycemic Agents 20%
• Prescriptions 17%
• Statistics 16%
• Costs and Cost Analysis 13%
• Kidney 11%
• Incidence 10%
• Population 8%
• Therapeutics 6%